Literature DB >> 15034839

Interval between births and risk of congenital cytomegalovirus infection.

Karen B Fowler1, Sergio Stagno, Robert F Pass.   

Abstract

To examine the effect of the interval between maternal cytomegalovirus (CMV) infection and conception on the risk of congenital CMV infection, the congenital CMV infection rate was evaluated relative to the intervals between deliveries in young women. Among mothers who seroconverted between deliveries, the rate of congenital CMV infection among their offspring was highest when the delivery interval was < or =24 months. However, the risk of transmission remained elevated for women with delivery intervals of 25-48 months and for those with delivery intervals >48 months apart.

Entities:  

Mesh:

Year:  2004        PMID: 15034839     DOI: 10.1086/382533

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  13 in total

1.  Influence of parity and sexual history on cytomegalovirus seroprevalence among women aged 20-49 years in the USA.

Authors:  Tatiana M Lanzieri; Deanna Kruszon-Moran; Manoj Gambhir; Stephanie R Bialek
Journal:  Int J Gynaecol Obstet       Date:  2016-06-29       Impact factor: 3.561

2.  Vaccine prevention of maternal cytomegalovirus infection.

Authors:  Robert F Pass; Changpin Zhang; Ashley Evans; Tina Simpson; William Andrews; Meei-Li Huang; Lawrence Corey; Janie Hill; Elizabeth Davis; Cynthia Flanigan; Gretchen Cloud
Journal:  N Engl J Med       Date:  2009-03-19       Impact factor: 91.245

Review 3.  Development and evidence for efficacy of CMV glycoprotein B vaccine with MF59 adjuvant.

Authors:  Robert F Pass
Journal:  J Clin Virol       Date:  2009-07-31       Impact factor: 3.168

Review 4.  Cytomegalovirus vaccine development.

Authors:  M R Schleiss
Journal:  Curr Top Microbiol Immunol       Date:  2008       Impact factor: 4.291

5.  Human cytomegalovirus vaccine development: Immune responses to look into vaccine strategy.

Authors:  Lin Xia; Ruopeng Su; Zhiqiang An; Tong-Ming Fu; Wenxin Luo
Journal:  Hum Vaccin Immunother       Date:  2017-12-01       Impact factor: 3.452

6.  Evaluation of the new architect cytomegalovirus immunoglobulin M (IgM), IgG, and IgG avidity assays.

Authors:  K Lagrou; M Bodeus; M Van Ranst; P Goubau
Journal:  J Clin Microbiol       Date:  2009-04-01       Impact factor: 5.948

7.  Seroprevalence of cytomegalovirus infection in France in 2010.

Authors:  D Antona; A Lepoutre; L Fonteneau; C Baudon; F Halftermeyer-Zhou; Y LE Strat; D Lévy-Bruhl
Journal:  Epidemiol Infect       Date:  2017-02-07       Impact factor: 4.434

8.  Toxoplasmosis, cytomegalovirus, listeriosis, and preconception care.

Authors:  Danielle S Ross; Jeffery L Jones; Michael F Lynch
Journal:  Matern Child Health J       Date:  2006-09

9.  High susceptibility to cytomegalovirus infection of pregnant women in Flanders, Belgium.

Authors:  E Leuridan; M Ieven; N Hens; P Van Damme
Journal:  Facts Views Vis Obgyn       Date:  2012

10.  Low Maternal Immunoglobulin G Avidity and Single Parity as Adverse Implications of Human Cytomegalovirus Vertical Transmission in Pregnant Women with Immunoglobulin M Positivity.

Authors:  Masatoki Kaneko; Junsuke Muraoka; Kazumi Kusumoto; Toshio Minematsu
Journal:  Viruses       Date:  2021-05-09       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.